Vitrolife AB (publ) (VTRLY)
OTCMKTS
· Delayed Price · Currency is USD
14.90
+0.28 (1.92%)
Jun 24, 2025, 9:46 AM EDT
Vitrolife AB Revenue
Vitrolife AB had revenue of 842.00M SEK in the quarter ending March 31, 2025, with 0.12% growth. This brings the company's revenue in the last twelve months to 3.61B, up 3.17% year-over-year. In the year 2024, Vitrolife AB had annual revenue of 3.61B with 2.76% growth.
Revenue (ttm)
3.61B SEK
Revenue Growth
+3.17%
P/S Ratio
5.36
Revenue / Employee
3.09M SEK
Employees
1,169
Market Cap
1.93B USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.61B | 97.00M | 2.76% |
| Dec 31, 2023 | 3.51B | 278.00M | 8.60% |
| Dec 31, 2022 | 3.23B | 1.55B | 92.39% |
| Dec 31, 2021 | 1.68B | 435.43M | 34.96% |
| Dec 31, 2020 | 1.25B | -234.56M | -15.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Elite Pharmaceuticals | 70.00M |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| American Oncology Network | 1.76B |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
Vitrolife AB News
- 2 months ago - Vitrolife names Pär Ihrskog as finance chief - Seeking Alpha
- 5 months ago - Vitrolife AB (publ) GAAP EPS of SEK1.02, revenue of SEK 959M - Seeking Alpha
- 7 months ago - Vitrolife CFO Patrik Tolf to step down - Seeking Alpha
- 8 months ago - Vitrolife AB (publ) reports Q3 results - Seeking Alpha